Saturday, July 11, 2026

Drug profile · INN

rolapitant

rolapitant (VARUBY) is a neurokinin 1 receptor antagonist.

EMA: withdrawn Alimentary tract and metabolism (A04) A04AD
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — rolapitant
Class
Alimentary tract and metabolism (A04)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

rolapitant (VARUBY) is a neurokinin 1 receptor antagonist.

Key facts

INN rolapitant
Brand VARUBY
Mechanism Neurokinin 1 receptor antagonist
Therapeutic class Alimentary tract and metabolism (A04)
ATC code A04AD

Mechanism of action

Neurokinin 1 receptor antagonist

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is rolapitant?

rolapitant (VARUBY) is a neurokinin 1 receptor antagonist.

What is the brand name for rolapitant?

VARUBY is a marketed brand name for rolapitant. Check FDA Drugs@FDA for the current US label holder and prescribing information.